Sapio Sciences, the science-awareTM AI lab informatics platform, today announced the appointment of Rich Roda as Chief Financial Officer. Roda brings more than two decades of financial leadership across technology, healthcare, and professional services, with a proven track record of scaling finance operations for growth-stage and private equity–backed companies.
Kevin Cramer, CEO and CTO at Sapio Sciences, commented, “The biopharma industry is facing rising R&D costs, increasingly complex data, and pressure to accelerate time-to-market for new therapies. Technology, and especially AI, will be critical to overcoming these hurdles and shaping the future of pharmaceuticals and therapeutics.”
Appointing Rich as CFO ensures we have the financial leadership to support our global growth goals, while continuing to innovate across Sapio’s AI-native lab informatics platform, like AILN and ELaiN.
Cramer continued.
Sapio is transforming biopharma R&D, providing an AI-native platform that integrates LIMS, ELN, and scientific data management in a unified environment. The appointment of Roda as CFO reinforces the company’s commitment to building a robust financial foundation that supports innovation, customer success, and sustainable long-term growth.
Gordon McCall, COO at Sapio Sciences, commented, “Rich has a rare combination of financial discipline and growth-focused leadership. His experience in building finance functions that enable companies to scale efficiently makes him an ideal addition to our executive team as we enter our next phase of growth.”
Roda joins Sapio from Tiugo Technologies, an affiliate of PSG, where he has served as Chief Financial Officer since 2022. At Tiugo, he played a key role in integrating and scaling a portfolio of SDK and API-based software companies serving developer communities. Prior to Tiugo, Roda held senior finance leadership roles at SimSpace, EngageSmart, Cengage Learning, HealthEdge, Nuance, Constant Contact, McKinsey & Company, and IBM.
Rich Roda, CFO, Sapio Sciences added, “Sapio’s leadership in R&D and lab AI is reshaping how science gets done. I’m excited to join at such a pivotal moment to help scale the company’s operations and ensure the financial strength that supports sustainable growth. By aligning fiscal discipline with Sapio’s breakthrough AI solutions such as AILN and ELaiN, we can accelerate the impact we deliver for customers worldwide.”